Add time:08/21/2019 Source:sciencedirect.com
bolesatine (cas 123896-30-0), a toxic protein isolated from Boletus satanas Lenz inhibits in vitro protein synthesis in a concentration-dependent manner in a cell line from a radiation-induced thymic lymphosarcoma (SP2/O) with a 50% inhibitory concentration (IC50) of 9.5 nM (0.6 μg/ml). In vivo, an i.p. single injection of bolesatine, corresponding to 16 and 110 of 24-h 50% lethal dose, in Balb/c mice having ascitic tumour induced by the i.p. preinjection of SP2/O cells allows a remission of 50% and 30%, respectively. Treated mice survived 120 days after the treatment i.e. 90 days after the death of control animals.
We also recommend Trading Suppliers and Manufacturers of bolesatine (cas 123896-30-0). Pls Click Website Link as below: cas 123896-30-0 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View